These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35080767)

  • 1. [Overview of immune-related side effects from immune checkpoint inhibitors. Part 1: Gastrointestinal, lung and kidney toxicity].
    Villabona Lisa Villabona L; Costa Svedman F; Jovanovic B; Kaneteg B; Eberhardson M; Magin H; Ullenhag G; Blomqvist L; Helgadottir H
    Lakartidningen; 2021 Nov; 118():. PubMed ID: 35080767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overview of immune-related side effects from immune checkpoint inhibitors. Part 2: Endocrine, rheumatologic and skin toxicity].
    Helgadottir H; Falkenius J; Eriksson H; Girnita A; Sahlberg L; Bensing S; Chatzidionysiou K; Masucci G; Ullenhag G
    Lakartidningen; 2021 Nov; 118():. PubMed ID: 35080768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors.
    Chhabra N; Kennedy J
    J Med Toxicol; 2021 Oct; 17(4):411-424. PubMed ID: 33826117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer.
    Rahman MM; Behl T; Islam MR; Alam MN; Islam MM; Albarrati A; Albratty M; Meraya AM; Bungau SG
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Part 1: Imaging findings of common immune checkpoint inhibitor-related adverse effects.
    Noë G; Cardin A; Lasocki A
    J Med Imaging Radiat Oncol; 2022 Jun; 66(4):495-501. PubMed ID: 35244329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis.
    Wang H; Guo X; Zhou J; Li Y; Duan L; Si X; Zhang L; Liu X; Wang M; Shi J; Zhang L
    Thorac Cancer; 2020 Jan; 11(1):191-197. PubMed ID: 31762218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Gastrointestinal Side Effects of Immune Checkpoint Inhibitors.
    Lui RN; Chan SL
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2262-2265. PubMed ID: 34324843
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of immune checkpoint inhibitor-related dermatologic adverse events.
    Si X; He C; Zhang L; Liu X; Li Y; Wang H; Guo X; Zhou J; Duan L; Wang M; Zhang L
    Thorac Cancer; 2020 Feb; 11(2):488-492. PubMed ID: 31814310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune-related adverse events of checkpoint inhibitors: an internist/general practitioner's point of view].
    Cisarovsky C; Kraege V; Obeid M; Garnier A
    Rev Med Suisse; 2020 Nov; 16(716):2264-2270. PubMed ID: 33237644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Etiology of Hypophysitis: Immune Checkpoint Inhibitors.
    Fernandes S; Varlamov EV; McCartney S; Fleseriu M
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):387-399. PubMed ID: 32741478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy.
    Chau J; Zhang J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy and the management of side effects.
    Mahalingam P; Newsom-Davis T
    Clin Med (Lond); 2023 Jan; 23(1):56-60. PubMed ID: 36697001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors.
    Jia XH; Geng LY; Jiang PP; Xu H; Nan KJ; Yao Y; Jiang LL; Sun H; Qin TJ; Guo H
    J Exp Clin Cancer Res; 2020 Dec; 39(1):284. PubMed ID: 33317597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and management of the gastrointestinal and hepatic immune-related adverse events.
    Tan B; Li Y; Xu Y; Chen M; Wang M; Qian J
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):95-102. PubMed ID: 32077625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.
    Ruste V; Goldschmidt V; Laparra A; Messayke S; Danlos FX; Romano-Martin P; Champiat S; Voisin AL; Baldini C; Massard C; Laghouati S; Marabelle A; Lambotte O; Michot JM
    Eur J Cancer; 2021 Nov; 158():217-224. PubMed ID: 34627664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
    Martins F; Sofiya L; Sykiotis GP; Lamine F; Maillard M; Fraga M; Shabafrouz K; Ribi C; Cairoli A; Guex-Crosier Y; Kuntzer T; Michielin O; Peters S; Coukos G; Spertini F; Thompson JA; Obeid M
    Nat Rev Clin Oncol; 2019 Sep; 16(9):563-580. PubMed ID: 31092901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitors renal side effects and management.
    Rassy EE; Kourie HR; Rizkallah J; Karak FE; Hanna C; Chelala DN; Ghosn M
    Immunotherapy; 2016 Dec; 8(12):1417-1425. PubMed ID: 28000536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunistic autoimmunity secondary to cancer immunotherapy (OASI): An emerging challenge.
    Kostine M; Chiche L; Lazaro E; Halfon P; Charpin C; Arniaud D; Retornaz F; Blanco P; Jourde-Chiche N; Richez C; Stavris C
    Rev Med Interne; 2017 Aug; 38(8):513-525. PubMed ID: 28214182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience.
    Fortes BH; Liou H; Dalvin LA
    Br J Ophthalmol; 2021 Sep; 105(9):1263-1271. PubMed ID: 32830124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
    Franzin R; Netti GS; Spadaccino F; Porta C; Gesualdo L; Stallone G; Castellano G; Ranieri E
    Front Immunol; 2020; 11():574271. PubMed ID: 33162990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.